Advertisement
-
1
Pereira de Godoy JM, Vasconcelos Ribeiro J, Caracanhas LA: Mortality and diabetes mellitus in amputations of the lower limbs for gas gangrene: a case report. Int J Low Extrem Wounds 7: 239, 2008.
-
2
Kuy S, Romero RA, Kuy S: Gas gangrene of the diabetic foot. J La State Med Soc 167: 213, 2015.
-
3
Dinubile MJ: Complicated infections of skin and skin structures: when the infection is more than skin deep. J Antimicrob Chemother 53(suppl 2): ii37, 2004.
-
4
Brucato MP, Patel K, Mgbako O: Diagnosis of gas gangrene: does a discrepancy exist between the published data and practice. J Foot Ankle Surg 53: 137, 2014.
-
5
Bessman AN: Nonclostridial gas gangrene. JAMA 233: 958, 1975.
-
6
Nichols RL, Smith JW: Gas in the wound: what does it mean? Surg Clin North Am 55: 1289, 1975.
-
7
Weinstein L, Barza MA: Gas gangrene. N Engl J Med 289: 1129, 1973.
-
8
Andrews FW, Horder, TJ: A study of the streptococci pathogenic for man. III. Proposed classification of streptococci based upon all characters and including Gordon's tests. Lancet 2: 711, 1906.
-
9
Cooper JD, Gotoff RA: Streptococcus anginosus purulent pericarditis with contiguous hepatic and subdiaphragmatic fluid collections: first reported case. Infect Dis Clin Pract 24: e37, 2016.
-
10
Siegman-Igra Y, Azmon Y, Schwartz D: Milleri group streptococcus: a stepchild in the viridans family. Eur J Clin Microbiol Infect Dis 31: 2453, 2012.
-
11
Facklam R: What happened to the streptococci: overview of taxonomic and nomenclature changes. Clin Microbiol Rev 15: 613, 2002.
-
12
Gossling J: Occurrence and pathogenicity of the Streptococcus milleri group. Clin Infect Dis 10: 257, 1988.
-
13
Piscitelli SC, Shwed J, Schreckenberger P, et al: Streptococcus milleri group: renewed interest in an elusive pathogen. Eur J Clin Microbiol Infect Dis 11: 491, 1992.
-
14
Whiley RA, Beighton D: Emended descriptions and recognition of Streptococcus constellatus, Streptococcus intermedius, and Streptococcus anginosus as distinct species. Int J Syst Bacteriol 41: 1, 1991.
-
15
Asam D, Spellerberg B: Molecular pathogenicity of Streptococcus anginosus. Mol Oral Microbiol 29: 145, 2014.
-
16
Wanahita A, Goldsmith EA, Musher DM, et al: Interaction between human polymorphonuclear leukocytes and Streptococcus milleri group bacteria. J Infect Dis 185: 85, 2002.
-
17
Claridge JE III, Attorri S, Musher DM, et al: Streptococcus intermedius, Streptococcus constellatus, and Streptococcus anginosus (“Streptococcus milleri group”) are of different clinical importance and are not equally associated with abscess. Clin Infect Dis 32: 1511, 2001.
A Rare Case of Myonecrosis with Soft-Tissue Emphysema in a Diabetic Foot Caused by Streptococcus anginosus Isolated in Pure Culture: A Case Study
Streptococcus anginosus (SAG) is a known human pathogen and member of the Streptococcus milleri group. SAG is a known bacterial cause of soft-tissue abscesses and bacteremia and is an increasingly prevalent pathogen in infections in patients with cystic fibrosis. We describe a rare case of SAG as an infectious agent in a case of nonclostridial myonecrosis with soft-tissue emphysema. This is the only case found in the literature of SAG cultured as a pure isolate in this type of infection and was associated with a prolonged course of treatment in an otherwise healthy patient.
